Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (574)

« Back to Publications

Convergent proteogenomic evidence prioritises five causal proteins and new drug targets for major psychiatric disorders

Margelyte R. et al, (2026)

Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorder.

Harder A. et al, (2026)

Integrating Multi-Omics Summary Data Identifies Candidate Molecular Mechanisms for Major Depression.

Nisbet L. et al, (2026), Biological psychiatry, 99, 1120 - 1129

Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorder.

Ter Kuile AR. et al, (2026), Molecular psychiatry

Genome-wide meta-analysis of quantitatively measured generalized anxiety symptoms in individuals of European ancestry.

Skelton M. et al, (2026), Nature human behaviour

"There's no representation": a qualitative study of attitudes and motivations towards genomic research participation among Australian South Asians.

Nathan V. et al, (2026), European journal of human genetics : EJHG

Extensive antagonistic variants across the human genome.

Bian B. et al, (2026), Nature communications

Poor mood after oral contraceptive use is associated with increased vulnerability to peripartum depression, premenstrual dysphoric disorder, and higher genetic risk for depression.

Kiewa J. et al, (2026), Archives of women's mental health, 29

Author Correction: Genome-wide fine-mapping improves identification of causal variants.

Wu Y. et al, (2026), Nature genetics

Progress in understanding the biological basis of polygenic disorders.

Wray NR. et al, (2026), Current opinion in genetics & development, 97

Psychiatric Nosology Should Include Genetic Syndromes.

Wray NR. and Owen MJ., (2026), Biological psychiatry, 99, 508 - 510

Empirical evaluation of analytic validity of polygenic scores.

Lin T. et al, (2026), Genome medicine

Genome-wide meta-analyses of non-response to antidepressants provide insights into underlying molecular genetics and suggest potential pharmacotherapies.

Koch E. et al, (2026), Molecular psychiatry, 31, 2005 - 2013

Genetic and Phenotypic Associations With Sustained Antidepressant Use in Major Depressive Disorder.

Walker A. et al, (2026), JAMA psychiatry, 83, 247 - 258

Phenome-Wide Associations of Polygenic Scores for Schizophrenia and Major Depression in 100,000 Chinese Adults.

Wang B. et al, (2026), Biological psychiatry global open science, 6

Genome-wide fine-mapping improves identification of causal variants.

Wu Y. et al, (2026), Nature genetics

Effects of 6-months of SSRI use on DNA-methylation and gene expression in blood.

Barker LF. et al, (2026), Brain, behavior, and immunity, 135

Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology.

Jiang J-C. et al, (2026), Translational psychiatry, 16

Cohort Profile: Investigating Antidepressant Response within Generation Scotland

Calnan M. et al, (2026)

From GWAS to drug: A framework for drug candidate prioritisation using a gene expression signature matching approach

Chauquet S. et al, (2026)

Load More

1
2
3
4
5
6
7
...
»